Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/07/2003WO2003065006A2 Methods and compositions for treating cancer
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064665A2 Viral vector
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064463A2 Pluripotency determining factors and uses thereof
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064454A1 Fap-activated anti-tumor compounds
08/07/2003WO2003064453A2 Trojan inhibitors, method for the production and use thereof
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003WO2003064440A1 Compounds that inhibit factor xa activity
08/07/2003WO2003064429A1 Thienopyrimidines, process for preparing the same and use thereof
08/07/2003WO2003064427A1 Tetrapyrrolic macrocycles as photodynamic agents
08/07/2003WO2003064426A1 N, n'-dimethylated n-confused porphyrins
08/07/2003WO2003064424A2 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
08/07/2003WO2003064413A1 Quinazoline compounds
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064378A2 Novel compounds that inhibit factor xa activity
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063901A1 Amino-substituted hypocrellins for use as sonosensitizers
08/07/2003WO2003063897A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
08/07/2003WO2003063896A1 Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063883A1 Mkrtachian embryonal antitumoral modulator, method for the production and use thereof
08/07/2003WO2003063875A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063866A1 Agents which interact with a serotonin transporter for the treatment of cancer
08/07/2003WO2003063860A1 Compositions for preventing human cancer and method of preventing human cancer
08/07/2003WO2003063859A1 Suppression of cartilage degradation via the estrogen receptor
08/07/2003WO2003063850A1 Medicinal compositions containing vitamin k’s as nerve growth factor potentiator and utilization thereof
08/07/2003WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/07/2003WO2003063796A2 Heterocyclic arylsulfonamidobenzylic compounds
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063770A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor
08/07/2003WO2003018788B1 Improved nitroreductase enzymes
08/07/2003WO2003018742A3 Recombinant l-asparaginase erwinia caratovora
08/07/2003WO2003011873A8 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
08/07/2003WO2002096948A3 Engineered tetravalent antibodies and methods of use
08/07/2003WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers
08/07/2003WO2002072627A3 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
08/07/2003WO2002068615A3 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
08/07/2003WO2002055541A3 Peptides having inhibiting activity on the production of nitric oxide
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002024222A3 Ligands for g protein coupled receptors and methods of using them
08/07/2003WO2002018608A9 Methods for enhancing the efficacy of cancer therapy
08/07/2003WO2002016559A3 In vivo animal model of human leukemia
08/07/2003WO2002015921A3 Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
08/07/2003WO2002004015A9 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003WO2002000172A3 Methods for using tetanus toxin for benificial purposes in animals (mammals)
08/07/2003WO2001092578A3 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149268 Administering non-steroidal 9-pyrido(3,2-g)quinoline compounds to the mammal for affecting androgen receptor activity
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149261 2'/3'-O-acetyl-ADP-ribose is produced by reacting Sir2 enzymes with acetylated peptide substrate (p53 genes) and NAD+; anticancer agents
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149113 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor
08/07/2003US20030149087 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
08/07/2003US20030149085 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
08/07/2003US20030149084 Cytostatic agents
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149079 Novel benzofuran derivatives
08/07/2003US20030149072 As anticancer agents, inhibitory activity on tubulin polymerization
08/07/2003US20030149068 Use of chrysanthone A for the preparation of a medicament with antiangiogenic activity
08/07/2003US20030149064 Pyrimidine compounds
08/07/2003US20030149063 For therapy of ras- oncogene-dependent tumors, such as cancers of pancreas, colon, bladder, and thyroid; useful for controlling metastasis, suppressing angiogenesis, inducing apoptosis, and Ras-associated proliferative diseases
08/07/2003US20030149058 Use of dipyridamole or mopidamol for treatment and prevention of fibrin-dependent microcirculation disorders
08/07/2003US20030149057 Anti-cancer compounds
08/07/2003US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149048 For therapy of hyperproliferative disorder in a mammal
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030149034 Indazoles substituted with1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149025 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
08/07/2003US20030149011 Methods and reagents for extracorporeal immunomodulatory therapy
08/07/2003US20030149010 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 2211